Brainmarker-I Differentially Predicts Remission to Various Attention-Deficit/Hyperactivity Disorder Treatments: A Discovery, Transfer, and Blinded Validation Study.

MLA

Voetterl, Helena, et al. “Brainmarker-I Differentially Predicts Remission to Various Attention-Deficit/Hyperactivity Disorder Treatments: A Discovery, Transfer, and Blinded Validation Study.” Biological Psychiatry. Cognitive Neuroscience and Neuroimaging, vol. 8, no. 1, Jan. 2023, pp. 52–60. EBSCOhost, https://doi.org/10.1016/j.bpsc.2022.02.007.

APA

Voetterl, H., van Wingen, G., Michelini, G., Griffiths, K. R., Gordon, E., DeBeus, R., Korgaonkar, M. S., Loo, S. K., Palmer, D., Breteler, R., Denys, D., Arnold, L. E., du Jour, P., van Ruth, R., Jansen, J., van Dijk, H., & Arns, M. (2023). Brainmarker-I Differentially Predicts Remission to Various Attention-Deficit/Hyperactivity Disorder Treatments: A Discovery, Transfer, and Blinded Validation Study. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging, 8(1), 52–60. https://doi.org/10.1016/j.bpsc.2022.02.007

Chicago

Voetterl, Helena, Guido van Wingen, Giorgia Michelini, Kristi R Griffiths, Evian Gordon, Roger DeBeus, Mayuresh S Korgaonkar, et al. 2023. “Brainmarker-I Differentially Predicts Remission to Various Attention-Deficit/Hyperactivity Disorder Treatments: A Discovery, Transfer, and Blinded Validation Study.” Biological Psychiatry. Cognitive Neuroscience and Neuroimaging 8 (1): 52–60. doi:10.1016/j.bpsc.2022.02.007.